Sphingosine-1-phosphate receptors as emerging targets for treatment of pain

Biochemical Pharmacology

Volumn 84, Issue 12, 2012, Pages 1551-1562

  Welch, Sandra P ^a   Sim Selley, Laura J ^a   Selley, Dana E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antinociception; FTY720; Hyperalgesia; S1P receptors; Sphingolipids; Sphingosine 1 phosphate

Indexed keywords

1 (HYDROXYMETHYL) 3 (3 OCTYLPHENYL)CYCLOBUTANE; 1 [1 AMINO 3 (4 OCTYLPHENYL)CYCLOPENTYL]METHANOL; 2 AMINO 2 (3 OCTYLPHENYLCARBAMOYL)ETHYL PHOSPHATE; 2 AMINO 2 [2 [4 (3 BENZYLOXYPHENYLTHIO) 2 CHLOROPHENYL]ETHYL] 1,3 PROPANEDIOL; 2 AMINO N(3 OCTYLPHENYL) 3 (PHOSPHONOOXY)PROPANAMAIDE; 2 AMMO NIO 4 [2 CHLORO 4 (3 PHENOXYPHENYLTHIO)PHENYL] 2 (HYDROXYMETHYL)BUTYL HYDROGEN PHOSPHATE; 2 UNDECYL THIAZOLIDINE 4 CARBOXYLIC ACID; 3 AMINO(3 HEXYLPHENYLAMIN) 4 OXOBUTYLPHOSPHONIC ACID; 4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; ANALGESIC AGENT; CANNABINOID RECEPTOR; CAY 10444; CYM 5442; FINGOLIMOD; G PROTEIN COUPLED RECEPTOR; ML 056; MORPHINE; MU OPIATE RECEPTOR; PHOSPHORIC ACID MONO[2 AMINO 2 (6 OCTYL 1H BENZOIMIAZOL 2 YL)ETHYL]ESTER; PHOSPHORIC ACID MONO[2 AMINO 3 (4 OCTYL PHENYLAMINO)PROPYL]ESTER; RIMONABANT; RPC 1063; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG; VPC 01091; VPC 03090; VPC 23153; VPC 24191; VPC 44116; W 146; [2 (4 (5 (3,4 DIETHOXYPHENYL) 1,2,4 OXADIAZOL 3 YL) 2,3 DIHYDRO 1H INDEN 1 YL AMINO)ETHANOL]; [3 AMINO 4 ((3 OCTYLPHENYL)AMINO) 4 OXOBUTYL]PHOSPHONIC ACID; [N (2,6 DICHLORO 4 PYRIDINYL) 2 (1,3 DIMETHYL 4 (1 METHYLETHYL) 1H PYRAZOLO[3,4 B]PYRI DIN 6 YL) HYDRAZINECARBOXAMIDE];

ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; AUTOIMMUNE DISEASE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CRYSTAL STRUCTURE; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG STRUCTURE; GENE DELETION; GLIA; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY PAIN; MULTIPLE SCLEROSIS; NERVE CELL; NEUROMODULATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN RECEPTOR; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SENSORY NERVE; TRANSGENIC ORGANISM;

EID: 84869221033     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.08.010     Document Type: Note

References (76)

1. V. Brinkmann Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology Pharmacol Ther 115 2007 84 105
2. M.J. Lee, J.R. Van Brocklyn, S. Thangada, C.H. Liu, A.R. Hand, and R. Menzeleev Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1 Science 279 1998 1552 1555
3. G.C.M. Zondag, F.R. Postma, I. VanEtten, I. Verlaan, and W.H. Moolenaar Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1 Biochem J 330 1998 605 609
4. R.E. Toman, and S. Spiegel Lysophospholipid receptors in the nervous system Neurochem Res 27 2002 619 627
5. L.J. Sim-Selley, P.B. Goforth, M.U. Mba, T.L. Macdonald, K.R. Lynch, and S. Milstien Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS J Neurochem 110 2009 1191 1202
6. N. Blondeau, Y. Lai, S. Tyndall, M. Popolo, K. Topalkara, and J.K. Pru Distribution of sphingosine kinase activity and mRNA in rodent brain J Neurochem 103 2007 509 517
7. L. Bryan, T. Kordula, S. Spiegel, and S. Milstien Regulation and functions of sphingosine kinases in the brain Biochim Biophys Acta 1781 2008 459 466
8. L.C. Edsall, and S. Spiegel Enzymatic measurement of sphingosine 1-phosphate Anal Biochem 272 1999 80 86
9. H. Rosen, and J. Liao Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigm Curr Opin Chem Biol 7 2003 461 468
10. R.G. Pertwee, A.C. Howlett, M.E. Abood, S.P. Alexander, V. Di Marzo, and M.R. Elphick International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB and CB Pharmacol Rev 62 2010 588 631
11. M. Maceyka, K.B. Harikumar, S. Milstien, and S. Spiegel Sphingosine-1-phosphate signaling and its role in disease Trends Cell Biol 22 2012 50 60
12. H. Le Stunff, S. Milstien, and S. Spiegel Generation and metabolism of bioactive sphingosine-1-phosphate J Cell Biochem 92 2004 882 899
13. K. Takabe, S.W. Paugh, S. Milstien, and S. Spiegel Inside-out signaling of sphingosine-1-phosphate: therapeutic targets Pharmacol Rev 60 2008 181 195
14. X. Jiang, and X. Han Characterization and direct quantitation of sphingoid base-1-phosphates from lipid extracts: a shotgun lipidomics approach J Lipid Res 47 2006 1865 1873
15. N. Terada, Y. Banno, N. Ohno, Y. Fujii, T. Murate, and J.R. Sarna Compartmentation of the mouse cerebellar cortex by sphingosine kinase J Comp Neurol 469 2004 119 127
16. J. Qin, E. Berdyshev, J. Goya, V. Natarajan, and G. Dawson Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis J Biol Chem 285 2010 14134 14143
17. V. Anelli, R. Bassi, G. Tettamanti, P. Viani, and L. Riboni Extracellular release of newly synthesized sphingosine-1-phosphate by cerebellar granule cells and astrocytes J Neurochem 92 2005 1204 1215
18. V. Brinkmann, A. Billich, T. Baumruker, P. Heining, R. Schmouder, and G. Francis Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Nat Rev Drug Discov 9 2010 883 897
19. J.M. Kovarik, R.L. Schmouder, and A.J. Slade Overview of FTY720 clinical pharmacokinetics and pharmacology Ther Drug Monit 26 2004 585 587
20. S. Mandala, R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, and J. Milligan Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists Science 296 2002 346 349
21. V. Brinkmann, and K.R. Lynch FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity Curr Opin Immunol 14 2002 569 575
22. G.M. Meno-Tetang, H. Li, S. Mis, N. Pyszczynski, P. Heining, and P. Lowe Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4- octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses Drug Metab Dispos 34 2006 1480 1487
23. C.A. Foster, L.M. Howard, A. Schweitzer, E. Persohn, P.C. Hiestand, and B. Balatoni Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis J Pharmacol Exp Ther 323 2007 469 475
24. C.W. Lee, J.W. Choi, and J. Chun Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis Arch Pharm Res 33 2010 1567 1574
25. K.R. Lynch, and T.L. Macdonald Sphingosine 1-phosphate chemical biology Biochim Biophys Acta 1781 2008 508 512
26. H. Rosen, P.J. Gonzalez-Cabrera, M.G. Sanna, and S. Brown Sphingosine 1-phosphate receptor signaling Annu Rev Biochem 78 2009 743 768
27. M.G. Sanna, J. Liao, E. Jo, C. Alfonso, M.Y. Ahn, and M.S. Peterson Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate J Biol Chem 279 2004 13839 13848
28. P.J. Gonzalez-Cabrera, E. Jo, M.G. Sanna, S. Brown, N. Leaf, and D. Marsolais Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions Mol Pharmacol 74 2008 1308 1318
29. H. Shimizu, M. Takahashi, T. Kaneko, T. Murakami, Y. Hakamata, and S. Kudou KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts Circulation 111 2005 222 229
30. R. Zhu, A.H. Snyder, Y. Kharel, L. Schaffter, Q. Sun, and P.C. Kennedy Asymmetric synthesis of conformationally constrained fingolimod analogues - discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonist J Med Chem 50 2007 6428 6435
31. A.S. Awad, H. Ye, L. Huang, L. Li, F.W. Foss, and T.L. Macdonald Selective sphingosine 1-phosphate receptor activation reduces ischemia-reperfusion injury in mouse kidney Am J Physiol Renal Physiol 290 2006 F1516 F1524
32. F.W. Foss Jr., A.H. Snyder, M.D. Davis, M. Rouse, M.D. Okusa, and K.R. Lynch Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists Bioorg Med Chem 15 2007 663 677
33. P.C. Kennedy, R. Zhu, T. Huang, J.L. Tomsig, T.P. Mathews, and M. David Characterization of a sphingosine-1-phosphate receptor antagonist prodrug J Pharmacol Exp Ther 338 2011 879 889
34. Kawasaki H, Ozawa K, Yamamoto K. Pyrazolopyridine compounds and use thereof as drugs. Patent WO 01/98301 A1 2001.
35. Y. Koide, T. Hasegawa, A. Takahashi, A. Endo, N. Mochizuki, and M. Nakakgawa Development of novel EDG3 antagonists using a 3D database search and their structure-activity relationships J Med Chem 45 2002 4629 4638
36. N.J. Pyne, and S. Pyne Selectivity and specificity of sphingosine 1-phosphate receptor ligands: off-targets or complex pharmacology? Front Pharmacol 2 2011 26
37. S. Salomone, E.M. Potts, S. Tyndall, P.C. Ip, J. Chun, and V. Brinkmann Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools Br J Pharmacol 153 2008 140 147
38. M.G. Sanna, S.K. Wang, P.J. Gonzalez-Cabrera, A. Don, D. Marsolais, and M.P. Matheu Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo Nat Chem Biol 2 2006 434 441
39. M.A. Hanson, C.B. Roth, E. Jo, M.T. Griffith, F.L. Scott, and G. Reinhart Crystal structure of a lipid G protein-coupled receptor Science 335 2012 851 855
40. M.L. Allende, T. Yamashita, and R.L. Proia G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation Blood 102 2003 3665 3667
41. A.H. Yang, I. Ishii, and J. Chun In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice Biochim Biophys Acta 1582 2002 197 203
42. J.W. Choi, C.W. Lee, and J. Chun Biological roles of lysophospholipid receptors revealed by genetic null mice: an update Biochim Biophys Acta 1781 2008 531 539
43. S. Pyne, S.C. Lee, J. Long, and N.J. Pyne Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease Cell Signal 21 2009 14 21
44. K. Mizugishi, T. Yamashita, A. Olivera, G.F. Miller, S. Spiegel, and R.L. Proia Essential role for sphingosine kinases in neural and vascular development Mol Cell Biol 25 2005 11113 11121
45. M.S. Beer, J.A. Stanton, K. Salim, M. Rigby, R.P. Heavens, and D. Smith EDG receptors as a therapeutic target in the nervous system Ann N Y Acad Sci 905 2000 118 131
46. T.S. Rao, K.D. Lariosa-Willingham, F.F. Lin, E.L. Palfreyman, N. Yu, and J. Chun Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes Brain Res 990 2003 182 194
47. N. Yu, K.D. Lariosa-Willingham, F.F. Lin, M. Webb, and T.S. Rao Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes Glia 45 2004 17 27
48. H. Nishimura, T. Akiyama, I. Irei, S. Hamazaki, and Y. Sadahira Cellular localization of sphingosine-1-phosphate receptor 1 expression in the human central nervous system J Histochem Cytochem 58 2010 847 856
49. 35S]thio)triphosphate binding stimulated by sphingosine 1-phosphate and lysophosphatidic acid J Neurochem 73 1999 1212 1221
50. T. Kajimoto, T. Okada, H. Yu, S.K. Goparaju, S. Jahangeer, and S. Nakamura Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons Mol Cell Biol 27 2007 3429 3440
51. T. Kanno, T. Nishizaki, R.L. Proia, T. Kajimoto, S. Jahangeer, and T. Okada Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus Neuroscience 171 2010 973 980
52. O. Coste, C. Brenneis, B. Linke, S. Pierre, C. Maeurer, and W. Becker Sphingosine 1-phosphate modulates spinal nociceptive processing J Biol Chem 283 2008 32442 32451
53. Y.H. Zhang, J.C. Fehrenbacher, M.R. Vasko, and G.D. Nicol Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons J Neurophysiol 96 2006 1042 1052
54. S.C. Sensken, C. Staubert, P. Keul, B. Levkau, T. Schoneberg, and M.H. Graler Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate Cell Signal 20 2008 1125 1133
55. S.W. Paugh, M.P. Cassidy, H. He, S. Milstien, L.J. Sim-Selley, and S. Spiegel Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4- octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor Mol Pharmacol 70 2006 41 50
56. Welch SP, Selley DE, Sim-Selley LJ. Interaction of S1P and FTY720 with opioid systems in the production of antinociception and opioid tolerance. College on Problems of Drug Dependence Abstract Monograph 2009; Oral Communications 10.
57. H. Ueda Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination Mol Pain 4 2008 11
58. O. Coste, S. Pierre, C. Marian, C. Brenneis, C. Angioni, and H. Schmidt Antinociceptive activity of the S1P-receptor agonist FTY720 J Cell Mol Med 12 2008 995 1004
59. C. Buzzi Fde, M. Fracasso, V.C. Filho, R. Escarcena, E. del Olmo, and A. San Feliciano New antinociceptive agents related to dihydrosphingosine Pharmacol Rep 62 2010 849 857
60. G.J. Patti, O. Yanes, L.P. Shriver, J.P. Courade, R. Tautenhahn, and M. Manchester Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin Nat Chem Biol 8 2012 232 234
61. J. Guindon, and A.G. Hohmann The endocannabinoid system and pain CNS Neurol Disord Drug Targets 8 2009 403 421
62. T. Doyle, A. Finley, Z. Chen, and D. Salvemini Role for peroxynitrite in sphingosine-1-phosphate-induced hyperalgesia in rats Pain 152 2011 643 648
63. T. Doyle, Z. Chen, L.M. Obeid, and D. Salvemini Sphingosine-1-phosphate acting via the S1P receptor is a downstream signaling pathway in ceramide-induced hyperalgesia Neurosci Lett 499 2011 4 8
64. X.X. Chi, and G.D. Nicol The sphingosine 1-phosphate receptor, S1PR, plays a prominent but not exclusive role in enhancing the excitability of sensory neurons J Neurophysiol 104 2010 2741 2748
65. N. Mair, C. Benetti, M. Andratsch, M.G. Leitner, C.E. Constantin, and M. Camprubi-Robles Genetic evidence for involvement of neuronally expressed S1P receptor in nociceptor sensitization and inflammatory pain PLoS One 6 2011 e17268
66. N. Agarwal, P. Pacher, I. Tegeder, F. Amaya, C.E. Constantin, and G.J. Brenner Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors Nat Neurosci 10 2007 870 879
67. A.J. Pernia-Andrade, A. Kato, R. Witschi, R. Nyilas, I. Katona, and T.F. Freund Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization Science 325 2009 760 764
68. S.P. Welch, and D.L. Stevens Antinociceptive activity of intrathecally administered cannabinoids alone and in combination with morphine in mice J Pharmacol Exp Ther 262 1992 10 18
69. J. Barnett-Norris, D. Lynch, and P.H. Reggio Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system Life Sci 77 2005 1625 1639
70. D. Meyer zu Heringdorf, H. Lass, I. Kuchar, M. Lipinski, R. Alemany, and U. Rumenapp Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors Eur J Pharmacol 414 2001 145 154
71. M. Guzman, I. Galve-Roperh, and C. Sanchez Ceramide: a new second messenger of cannabinoid action Trends Pharmacol Sci 22 2001 19 22
72. C. Muscoli, T. Doyle, C. Dagostino, L. Bryant, Z. Chen, and L.R. Watkins Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids J Neurosci 30 2010 15400 15408
73. S. Tsunemi, T. Iwasaki, S. Kitano, T. Imado, K. Miyazawa, and H. Sano Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model Clin Immunol 136 2010 197 204
74. J. Chun, T. Hla, K.R. Lynch, S. Spiegel, and W.H. Moolenaar International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature Pharmacol Rev 62 2010 579 587
75. M. Osada, Y. Yatomi, T. Ohmori, H. Ikeda, and Y. Ozaki Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist Biophys Res Commun 299 2002 483 487
76. Y. Koide, K. Uemoto, T. Hasegawa, T. Sada, A. Murakami, and H. Takasugi Pharmacophore-based design of sphingosine 1-phosphate-3 receptor antagonists that include a 3,4-dialkoxybenzophenone scaffold J Med Chem 50 2007 442 454